Skip to main content

ICU Acquired Weakness clinical trials at UC Health

1 research study open to eligible people

Showing trials for
  • Evaluation of FDY-5301 in Major Trauma Patients in ICU

    open to eligible people ages 18-75

    The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics (PK) of FDY-5301 compared to placebo in major trauma ICU patients at risk of intensive care unit acquired weakness (ICUAW)

    at UCLA

Last updated: